[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Akeso Inc.
Akeso Inc. announces first patient enrollment in Phase III trial for pancreatic cancer. Social engagement surges, but the price faces downward pressure.
About Akeso Inc.
Akeso Inc. is a healthcare company involved in clinical trials and market performance.
Insights #
- Akeso Inc. mentions is at XXX which is XXX% higher than it's daily average.
- Akeso Inc. creators is at XX which is XXX% higher than it's daily average.
- Akeso Inc. sentiment is up XXXXX% from the previous week.
- Akeso Inc. creators is up XXXXX% from the previous week.
- Akeso Inc. engagements is up XXXXXX% from the previous month.
- Akeso Inc. mentions is up XXXXX% from the previous week.
- Akeso Inc. Price hit a high of XXXXXX for the hour
- Akeso Inc. Price hit an all time of XXXXXX for the hour
Price: $XXXXXX #
Price 24-Hour Chart Data
The price is experiencing downward pressure due to mixed clinical trial results, negative user sentiment, and the recent merger of portfolio companies.
1-Year High: $XXXXXX on 2025-07-24
1-Year Low: $XXXXX on 2024-07-30
AltRank: undefined #
AltRank 24-Hour Chart Data
Akeso Inc. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXXXX on 2025-01-03
1-Year Low: XXX on 2025-02-27
Galaxy Score: XX #
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2024-11-29
1-Year Low: XX on 2025-06-27
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXXX +18%
1 Month: XXXXXXX +171%
6 Months: XXXXXXXXX +773%
1 Year: XXXXXXXXX +354%
1-Year High: XXXXXXX on 2025-03-27
1-Year Low: X on 2024-08-08
| Social Network | YouTube | X | TikTok | News | |
|---|---|---|---|---|---|
| Engagements | XXXXX | XXXXX | XX | XXX | X |
Mentions: XXX #
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Week: XXX +24%
1 Month: XXX +8.40%
6 Months: XXXXX +527%
1 Year: XXXXX +484%
1-Year High: XXX on 2025-04-26
1-Year Low: X on 2024-07-27
| Social Network | YouTube | X | TikTok | News | |
|---|---|---|---|---|---|
| Mentions | XX | XXX | XX | XX | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Akeso Inc. in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XXX +21%
1 Month: XXX +3.40%
6 Months: XXXXX +564%
1 Year: XXXXX +465%
1-Year High: XXX on 2025-04-26
1-Year Low: X on 2024-07-27
The most influential creators that mention Akeso Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Forbes | X | XXXXXXXXXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +25%
1 Month: XX% -X%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-07-26
1-Year Low: XX% on 2025-07-08
Most Supportive Themes
- Rising Engagement: (15%) Positive sentiment is increasing around Akeso with social engagement metrics showing significant growth.
- Partnerships and Deals: (15%) Posts highlight new deals and partnerships announced by Akeso Inc.
Most Critical Themes
- Negative Sentiment and Rants: (0.8%) Posts expressing negative sentiment and user issues.
- ADHD Diagnosis and Medical Concerns: (0.6%) Some users are discussing medical diagnoses and concerns related to Akeso.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| YouTube | XX | X% | XXXXX | XX% | X | X% |
| X | XX | X% | XXX | XX% | XX | X% |
| XX | X% | X | X% | X | X% | |
| TikTok | XXX | X% | XX | X% | XX | X% |
| News | X | X% | X | X% | X | X% |
| Total | XXX | X% | XXXXX | XX% | XXX | X% |
Market Cap: $undefined #
Market Cap 24-Hour Chart Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXX on 2025-04-01
1-Year Low: $XXXXXXXXXXXXXX on 2024-07-30
Top assets mentioned In the posts about Akeso Inc. in the last XX hours
Summit Therapeutics Inc. Common Stock (SMMT) Merck & Co., Inc. (MRK) Lemonade, Inc. (LMND) Pfizer, Inc. (PFE) Bitcoin Incognito (XBI) Swap (XWP) AstraZeneca PLC (AZN) Spotify Technology (SPOT)
Top topics mentioned In the posts about Akeso Inc. in the last XX hours
china, $smmt, coins healthcare, billionaires, women, haka, $ntcjo, forbes, #fyp, $mrk, stocks healthcare, stocks, money, coins ai, tracker, all the, drugs, hang seng, investment, wsj, mental health, tiktok, med, abc, told, le, $lmnd, toh, har, $pfe, $pph, $xph, $ibb, $xbi, web3, fin, $1530hk, beta, baddie, trumps, jj, $30b, the worlds, blocks, pfe, $bntx, collab, facilities, insurance, manat, $12b, $200m, united states, breakthrough, definitive, $vtgnpremarket, $130b, fu, $reymi, $xwp, ia, ji, ford, rey, #viral, spa, res, #meme, stockmarket, ads, pets, beyonc, affordable, cowboy carter, south africa, ena, iv, nigeria, damn, middle east, minds, saka, new era, mai, jersey, willy, theblessnetwork, private equity, promptale, $avijo, mars, $15b, $azn, asap, eng, bana, papa, superior, arizona, rating agency
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Dan lami kudi akeso ba rufin asiriba 💔🤣"
@madawaky on X 2025-07-24 19:10:53 UTC 1433 followers, XX engagements
"Burnout: Whats at stake when living with chronic stress from parenting"
@capetalk567 on YouTube 2025-07-24 10:44:10 UTC 23.2K followers, X engagements
"A clinical psychologist and occupational therapist of Netcare Akeso Umhlangas COPE team unpack the troubling consequences of unmanaged chronic work stress emphasising that prevention is always better than rebuilding after crises. Full story here:"
@risingsunonline on X 2025-07-24 07:32:22 UTC XXX followers, XX engagements
"#mobiledista # Akeso Announces First Patient Enrollment in Phase III Trial of Ivonescimab for Pancreatic Cancer"
@mobiledista on X 2025-07-24 02:36:52 UTC XX followers, XX engagements